Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

NCT00119262 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

226

Enrollment

NIH

Sponsor class

Conditions

Male Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer

Interventions

DRUG: doxorubicin hydrochloride
DRUG: cyclophosphamide
BIOLOGICAL: bevacizumab
DRUG: paclitaxel
BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
RADIATION: radiation therapy
DRUG: tamoxifen citrate
DRUG: aromatase inhibition therapy

Sponsor

National Cancer Institute (NCI)